<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font8" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font10" size="8" family="GillSans,Bold" color="#000000"/>
<text top="41" left="55" width="114" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Biochemistry 2006, 7 :1<i>BMC Biochemistry</i></text>
<text top="41" left="373" width="181" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2091/7/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="101" segment_no="24" tag_type="text">Page 9 of 10<b>7</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="102" segment_no="25" tag_type="text">(page number not for citation purposes)</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="27" segment_no="4" tag_type="text">was added. 500 uL of BBS (0.05 M BES, 0.28 M NaCl,</text>
<text top="228" left="55" width="241" height="10" font="font4" id="p1_t6" reading_order_no="28" segment_no="4" tag_type="text">0.0015 M Na 2 HPO 4 , pH 7.0) was added and solution vor-</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="29" segment_no="4" tag_type="text">texed to mix. Cells were re-fed with fresh MEM supple-<i>(page number not for citation purposes)</i></text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="30" segment_no="4" tag_type="text">mented with 2.5 uL/mL 25-hydroxycholesterol (Sigma).</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="31" segment_no="4" tag_type="text">Precipitate was applied to cells and incubated for 4 hours</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="32" segment_no="4" tag_type="text">prior to removal with PBS. Cells were re-fed with fresh</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="33" segment_no="4" tag_type="text">MEM and incubated 24–48 hours. All plasmids used in</text>
<text top="298" left="55" width="128" height="9" font="font4" id="p1_t12" reading_order_no="34" segment_no="4" tag_type="text">this study are listed in Table 1.</text>
<text top="322" left="55" width="130" height="9" font="font6" id="p1_t13" reading_order_no="35" segment_no="7" tag_type="title">Construction of stable cell lines</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="36" segment_no="8" tag_type="text">HEK293 cells were transfected with pGC95 (control</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="37" segment_no="8" tag_type="text">scrambled shRNA, 5'-CGTGCAAGGTCAGTACATGT-</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="38" segment_no="8" tag_type="text">TCAAGAGACATGTACTGACCTTGCACG) or pGC93 (5'-</text>
<text top="369" left="55" width="228" height="9" font="font4" id="p1_t17" reading_order_no="39" segment_no="8" tag_type="text">TGCTCAGGCTGCTGCATATTTCAAGAGAATATGCAG-</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="40" segment_no="8" tag_type="text">CAGCCTGAGCA). 24 hours after transfection, cells were</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="41" segment_no="8" tag_type="text">re-fed with MEM supplemented with 5 ug/mL puromycin<a href=""> Table 1.</a></text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="42" segment_no="8" tag_type="text">and selected for 48 hours. Post-selection, cells were grown<i><b>Construction of stable cell lines</b></i></text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="43" segment_no="8" tag_type="text">for 7–10 days and single colonies were selected. Two rep-</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="44" segment_no="8" tag_type="text">resentative clonal expansions (1A and 2F) of pGC93 are</text>
<text top="439" left="55" width="31" height="9" font="font4" id="p1_t23" reading_order_no="45" segment_no="8" tag_type="text">shown.</text>
<text top="463" left="55" width="62" height="9" font="font6" id="p1_t24" reading_order_no="46" segment_no="11" tag_type="title">mRNA analysis</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="47" segment_no="12" tag_type="text">RNA was purified from cells using Qiagen RNeasy kits.</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="48" segment_no="12" tag_type="text">After purification, RNA was normalized by concentration</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="49" segment_no="12" tag_type="text">used as a template for stratascript reverse transcriptase fol-</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="50" segment_no="12" tag_type="text">lowing manufacturers protocols (stratagene). Reverse</text>
<text top="519" left="55" width="241" height="13" font="font4" id="p1_t29" reading_order_no="51" segment_no="12" tag_type="text">transcribed RNA was then used for PCR towards Csn5, β -</text>
<text top="533" left="55" width="185" height="9" font="font4" id="p1_t30" reading_order_no="52" segment_no="12" tag_type="text">Actin, cyclin F, Fbx4, Fbx7, Fbw7, and Skp2.</text>
<text top="557" left="55" width="65" height="9" font="font6" id="p1_t31" reading_order_no="53" segment_no="17" tag_type="title">Protein analysis<i><b>mRNA analysis</b></i></text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="54" segment_no="19" tag_type="text">Native lysates were made by resuspending cell pellets in</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="55" segment_no="19" tag_type="text">an equal volume of buffer A (25 mM TRIS (7.5), 150 mM</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="56" segment_no="19" tag_type="text">NaCl, 0.3% Triton X-100, 1 mM EDTA and 1 mM DTT</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="57" segment_no="19" tag_type="text">supplemented with 1 mM PMSF, 0.25 ug/mL pepstatin,</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="58" segment_no="19" tag_type="text">and 5 ug/mL each of leupeptin, aprotinin, and chymot-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="59" segment_no="19" tag_type="text">rypsin). Lysates were cleared by centrifugation and nor-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="60" segment_no="19" tag_type="text">malized using the Biorad Protein Assay (Biorad).</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="61" segment_no="19" tag_type="text">Denatured lysates were made by resuspending cell pellets</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="62" segment_no="19" tag_type="text">in an equal volume of boiling SDS buffer (2% SDS, 50<i><b>Protein analysis</b></i></text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="63" segment_no="19" tag_type="text">mM TRIS (7.5) and 5 mM DTT) and boiled for 5 minutes.</text>
<text top="686" left="55" width="222" height="9" font="font4" id="p1_t42" reading_order_no="64" segment_no="19" tag_type="text">Lysates were sonicated and cleared by centrifugation.</text>
<text top="216" left="313" width="44" height="9" font="font6" id="p1_t43" reading_order_no="65" segment_no="5" tag_type="title">Antibodies</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="66" segment_no="6" tag_type="text">The following antibodies were used in this study: Fbw7</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="67" segment_no="6" tag_type="text">(Orbigen PAB-10563), cyclin F (Santa Cruz Biotechnol-</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="68" segment_no="6" tag_type="text">ogy sc-952), cyclin E (Santa Cruz Biotechnology sc-198),</text>
<text top="261" left="313" width="241" height="13" font="font4" id="p1_t47" reading_order_no="69" segment_no="6" tag_type="text">Csn5 (Santa Cruz Biotechnology sc-9074), β -tubulin</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="70" segment_no="6" tag_type="text">(Santa Cruz Biotechnology sc-9104) Fbx7 (Zymed 51–</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="71" segment_no="6" tag_type="text">8000) and c-myc (Santa Cruz Biotechnology sc-42). Skp2</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="72" segment_no="6" tag_type="text">was generously provided by W. Krek and Fbx4 was gener-</text>
<text top="310" left="313" width="128" height="9" font="font4" id="p1_t51" reading_order_no="73" segment_no="6" tag_type="text">ously provided by W. Boelens.</text>
<text top="334" left="313" width="101" height="9" font="font6" id="p1_t52" reading_order_no="74" segment_no="9" tag_type="title">Histone H1 kinase assay<i><b>Antibodies</b></i></text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="75" segment_no="10" tag_type="text">Native lysates were immunoprecipitated for 1 hour with</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="76" segment_no="10" tag_type="text">antibodies toward cyclin E. Immunoprecipitates were</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="77" segment_no="10" tag_type="text">washed 3 times in native lysis buffer (buffer A). Beads</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="78" segment_no="10" tag_type="text">were resuspended in 10 uL of reaction mix (for 100 uL: 3</text>
<text top="390" left="313" width="241" height="13" font="font4" id="p1_t57" reading_order_no="79" segment_no="10" tag_type="text">uL 5 mg/mL histone H1, 1.5 uL 4.5 mM ATP, 1.5 uL γ - 32 P</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="80" segment_no="10" tag_type="text">ATP, 94 uL of kinase assay buffer (10 mM TRIS (7.5), 10</text>
<text top="416" left="313" width="241" height="10" font="font4" id="p1_t59" reading_order_no="81" segment_no="10" tag_type="text">mM MgCl 2 , 50 mM NaCl, 2 mM EDTA, 1 mM DTT and</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="82" segment_no="10" tag_type="text">0.02% Triton X-100)). Reactions were incubated for 20</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="83" segment_no="10" tag_type="text">minutes at 21°C and analyzed by SDS-PAGE followed by</text>
<text top="451" left="313" width="72" height="9" font="font4" id="p1_t62" reading_order_no="84" segment_no="10" tag_type="text">autoradiography.</text>
<text top="475" left="313" width="70" height="10" font="font8" id="p1_t63" reading_order_no="85" segment_no="13" tag_type="title">Abbreviations<i><b>Histone H1 kinase assay</b></i></text>
<text top="486" left="313" width="106" height="9" font="font4" id="p1_t64" reading_order_no="86" segment_no="14" tag_type="text">CSN: COP9/signalosome</text>
<text top="510" left="313" width="173" height="9" font="font4" id="p1_t65" reading_order_no="87" segment_no="15" tag_type="text">SCF: SKP1/Cullin/F-box protein complex</text>
<text top="533" left="313" width="205" height="9" font="font4" id="p1_t66" reading_order_no="88" segment_no="16" tag_type="text">JAMM: Jab1/MPN domain metalloenzyme motif</text>
<text top="557" left="313" width="219" height="9" font="font4" id="p1_t67" reading_order_no="89" segment_no="18" tag_type="text">BTB: "bric-a-brac/tramtrack/broad" protein complex</text>
<text top="580" left="313" width="114" height="10" font="font8" id="p1_t68" reading_order_no="90" segment_no="20" tag_type="title">Authors' contributions</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="91" segment_no="21" tag_type="text">All experiments were performed by GC. Both GC and RJD</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="92" segment_no="21" tag_type="text">conceived and designed the experiments. Both authors</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="93" segment_no="21" tag_type="text">contributed to the writing of the manuscript and both</text>
<text top="627" left="313" width="204" height="9" font="font4" id="p1_t72" reading_order_no="94" segment_no="21" tag_type="text">authors read and approved the final manuscript.</text>
<text top="651" left="313" width="99" height="10" font="font8" id="p1_t73" reading_order_no="95" segment_no="22" tag_type="title">Acknowledgements</text>
<text top="663" left="313" width="237" height="7" font="font9" id="p1_t74" reading_order_no="96" segment_no="23" tag_type="text">We thank W. Krek, W. Boelens, B. Clurman and S. Reed for generously</text>
<text top="673" left="313" width="241" height="7" font="font9" id="p1_t75" reading_order_no="97" segment_no="23" tag_type="text">providing antibodies and advice. We thank Nagesh Rao for performing FISH</text>
<text top="684" left="313" width="228" height="7" font="font9" id="p1_t76" reading_order_no="98" segment_no="23" tag_type="text">and kareotype analysis. We thank Rati Verma, Matt Petroski, Thibault</text>
<text top="694" left="313" width="241" height="7" font="font9" id="p1_t77" reading_order_no="99" segment_no="23" tag_type="text">Mayor and other members of the Deshaies lab for providing helpful insight</text>
<text top="705" left="313" width="153" height="7" font="font9" id="p1_t78" reading_order_no="100" segment_no="23" tag_type="text">and discussions during the course of this work.</text>
<text top="87" left="55" width="132" height="7" font="font10" id="p1_t79" reading_order_no="2" segment_no="2" tag_type="title">Table 1: Plasmids used in this study</text>
<text top="105" left="59" width="31" height="7" font="font10" id="p1_t80" reading_order_no="3" segment_no="3" tag_type="table">Plasmid<b>Abbreviations</b></text>
<text top="105" left="225" width="39" height="7" font="font10" id="p1_t81" reading_order_no="4" segment_no="3" tag_type="table">Reference</text>
<text top="105" left="392" width="45" height="7" font="font10" id="p1_t82" reading_order_no="5" segment_no="3" tag_type="table">Description</text>
<text top="127" left="59" width="24" height="7" font="font9" id="p1_t83" reading_order_no="6" segment_no="3" tag_type="table">pGC95</text>
<text top="127" left="225" width="34" height="7" font="font9" id="p1_t84" reading_order_no="7" segment_no="3" tag_type="table">This study</text>
<text top="127" left="392" width="133" height="7" font="font9" id="p1_t85" reading_order_no="8" segment_no="3" tag_type="table">Tetracycline inducible scrambled siRNA<b>Authors' contributions</b></text>
<text top="137" left="59" width="24" height="7" font="font9" id="p1_t86" reading_order_no="9" segment_no="3" tag_type="table">pGC93</text>
<text top="137" left="225" width="34" height="7" font="font9" id="p1_t87" reading_order_no="10" segment_no="3" tag_type="table">This study</text>
<text top="137" left="392" width="152" height="7" font="font9" id="p1_t88" reading_order_no="11" segment_no="3" tag_type="table">Tetracycline inducible siRNA to human Csn5.</text>
<text top="148" left="59" width="32" height="7" font="font9" id="p1_t89" reading_order_no="12" segment_no="3" tag_type="table">RJD 1419</text>
<text top="148" left="225" width="34" height="7" font="font9" id="p1_t90" reading_order_no="13" segment_no="3" tag_type="table">This study<b>Acknowledgements</b></text>
<text top="148" left="392" width="52" height="7" font="font9" id="p1_t91" reading_order_no="14" segment_no="3" tag_type="table">CMV Flag-Csn5</text>
<text top="158" left="59" width="32" height="7" font="font9" id="p1_t92" reading_order_no="15" segment_no="3" tag_type="table">RJD 1500</text>
<text top="158" left="225" width="34" height="7" font="font9" id="p1_t93" reading_order_no="16" segment_no="3" tag_type="table">This study</text>
<text top="158" left="392" width="75" height="7" font="font9" id="p1_t94" reading_order_no="17" segment_no="3" tag_type="table">CMV Flag-Csn5 (ASA)</text>
<text top="168" left="59" width="32" height="7" font="font9" id="p1_t95" reading_order_no="18" segment_no="3" tag_type="table">RJD 1501</text>
<text top="168" left="225" width="34" height="7" font="font9" id="p1_t96" reading_order_no="19" segment_no="3" tag_type="table">This study<b>Table 1: Plasmids used in this study</b></text>
<text top="168" left="392" width="85" height="7" font="font9" id="p1_t97" reading_order_no="20" segment_no="3" tag_type="table">CMV Flag-Csn5 (D151N)<b>Plasmid</b></text>
<text top="178" left="59" width="28" height="7" font="font9" id="p1_t98" reading_order_no="21" segment_no="3" tag_type="table">RJD 942<b>Reference</b></text>
<text top="178" left="225" width="14" height="7" font="font9" id="p1_t99" reading_order_no="22" segment_no="3" tag_type="table">[34]<b>Description</b></text>
<text top="178" left="392" width="30" height="7" font="font9" id="p1_t100" reading_order_no="23" segment_no="3" tag_type="table">HA-Cul1</text>
<text top="189" left="59" width="32" height="7" font="font9" id="p1_t101" reading_order_no="24" segment_no="3" tag_type="table">RJD 1192</text>
<text top="189" left="225" width="14" height="7" font="font9" id="p1_t102" reading_order_no="25" segment_no="3" tag_type="table">[27]</text>
<text top="189" left="392" width="58" height="7" font="font9" id="p1_t103" reading_order_no="26" segment_no="3" tag_type="table">HA-Cul1 (1–498)</text>
</page>
</pdf2xml>
